Morgan Stanley’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Morgan Stanley’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-42	Closed	-$38	–	8118
2024 Q2	$38	Sell	42 -29	-41%	-$33	﹤0.01%	7598
2024 Q1	$105	Hold	71	–	–	﹤0.01%	7370
2023 Q4	$82	Hold	71	–	–	﹤0.01%	7374
2023 Q3	$152	Buy	+71	New	+$172	﹤0.01%	7411
2023 Q2	–	Sell	-71	Closed	-$197	–	7720
2023 Q1	$197	Sell	71 -1	-1%	-$4	﹤0.01%	7519
2022 Q4	$192	Hold	72	–	–	﹤0.01%	7649
2022 Q3	$0	Buy	72 +1	+1%	+$7	﹤0.01%	7958
2022 Q2	$1K	Sell	71 -677	-91%	-$5.91K	﹤0.01%	7720
2022 Q1	$10K	Buy	748 +65	+10%	+$1.13K	﹤0.01%	7411
2021 Q4	$16K	Buy	683 +567	+489%	+$13.4K	﹤0.01%	7309
2021 Q3	$2K	Buy	+116	New	+$2.18K	﹤0.01%	7693

Other funds holding BTCY

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PWA

Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Morgan Stanley's BTCY Position: Q3 2024 in Review

Morgan Stanley sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 42 shares — an estimated $38 sold.

Morgan Stanley first reported a position in BTCY in Q3 2021 and held it in 11 quarters. The position peaked at $16K in Q4 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

Morgan Stanley reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Morgan Stanley sold 42 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $38.
Morgan Stanley first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
Morgan Stanley's Biotricity, Inc. Common Stock position peaked at $16K in Q4 2021.
5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.